Sökning: onr:"swepub:oai:DiVA.org:liu-97672" > Tumour PDGF-BB expr...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04464naa a2200565 4500 | |
001 | oai:DiVA.org:liu-97672 | |
003 | SwePub | |
008 | 130919s2013 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:127291200 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-976722 URI |
024 | 7 | a https://doi.org/10.1038/ncomms31292 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1272912002 URI |
040 | a (SwePub)liud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Hosaka, Kayokou Karolinska Institutet4 aut |
245 | 1 0 | a Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis |
264 | c 2013-07-08 | |
264 | 1 | b Nature Publishing Group: Nature Communications,c 2013 |
338 | a print2 rdacarrier | |
500 | a Funding Agencies|Swedish Research Council||Swedish Cancer Foundation||Karolinska Institute Foundation||Karolinska Institute||Tianjin Natural Science Foundation (CMM-Tianjin)|09ZCZDSF04400|Torsten Soderbergs foundation||European Union Integrated Project of Metoxia|222741|European Research Council (ERC)|250021| | |
520 | a Anti-platelet-derived growth factor (PDGF) drugs are routinely used in front-line therapy for the treatment of various cancers, but the molecular mechanism underlying their dose-dependent impact on vascular remodelling remains poorly understood. Here we show that anti-PDGF drugs significantly inhibit tumour growth and metastasis in high PDGF-BB-producing tumours by preventing pericyte loss and vascular permeability, whereas they promote tumour cell dissemination and metastasis in PDGF-BB-low-producing or PDGF-BB-negative tumours by ablating pericytes from tumour vessels. We show that this opposing effect is due to PDGF-beta signalling in pericytes. Persistent exposure of pericytes to PDGF-BB markedly downregulates PDGF-beta and inactivation of the PDGF-beta signalling decreases integrin alpha 1 beta 1 levels, which impairs pericyte adhesion to extracellular matrix components in blood vessels. Our data suggest that tumour PDGF-BB levels may serve as a biomarker for selection of tumour-bearing hosts for anti-PDGF therapy and unsupervised use of anti-PDGF drugs could potentially promote tumour invasion and metastasis. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Cell- och molekylärbiologi0 (SwePub)301082 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Cell and Molecular Biology0 (SwePub)301082 hsv//eng |
653 | a TECHNOLOGY | |
653 | a TEKNIKVETENSKAP | |
700 | 1 | a Yang, Yunlongu Karolinska Institutet4 aut |
700 | 1 | a Seki, Takahirou Karolinska Institutet4 aut |
700 | 1 | a Nakamura, Masakiu Karolinska Institutet4 aut |
700 | 1 | a Andersson, Patriku Karolinska Institutet4 aut |
700 | 1 | a Rouhi, Pegahu Karolinska Institute, Sweden4 aut |
700 | 1 | a Yang, Xiaojuanu Karolinska Institute, Sweden4 aut |
700 | 1 | a Jensen, Lasseu Karolinska Institutet,Linköpings universitet,Avdelningen för kardiovaskulär medicin,Hälsouniversitetet,Karolinska Institute, Sweden4 aut0 (Swepub:liu)larje86 |
700 | 1 | a Lim, Sharonu Karolinska Institutet4 aut |
700 | 1 | a Feng, Ninghanu Karolinska Institute, Sweden4 aut |
700 | 1 | a Xue, Yuanu Karolinska Institute, Sweden4 aut |
700 | 1 | a Li, Xuriu Sun Yat Sen University, Peoples R China4 aut |
700 | 1 | a Larsson, Olau Karolinska Institutet4 aut |
700 | 1 | a Ohhashi, Toshiou Shinshu University, Japan4 aut |
700 | 1 | a Cao, Yihaiu Linköpings universitet,Avdelningen för kardiovaskulär medicin,Hälsouniversitetet,Karolinska Institute, Sweden4 aut0 (Swepub:liu)yihca64 |
710 | 2 | a Karolinska Institutetb Karolinska Institute, Sweden4 org |
773 | 0 | t Nature Communicationsd : Nature Publishing Group: Nature Communicationsg 4:2129q 4:2129x 2041-1723 |
856 | 4 | u https://www.nature.com/articles/ncomms3129.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-97672 |
856 | 4 8 | u https://doi.org/10.1038/ncomms3129 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:127291200 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy